Consolidated Balance Sheet - USD ($) $ in Millions		Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and due from banks		$ 76,985	$ 61,192
Investment securities
Held-to-maturity (fair value $71,149 and $74,088, respectively)		82,948	84,045
Available-for-sale ($356 and $338 pledged as collateral, respectively)	[1]	72,426	69,706
Loans held for sale (including $1,885 and $2,011 of mortgage loans carried at fair value, respectively)		2,080	2,201
Loans
Total loans		374,588	373,835
Less allowance for loan losses		(7,514)	(7,379)
Net loans		367,074	366,456
Premises and equipment		3,537	3,623
Goodwill		12,479	12,489
Other intangible assets		6,031	6,084
Other assets (including $4,878 and $3,548 of trading securities at fair value pledged as collateral, respectively)	[1]	60,046	57,695
Total assets		683,606	663,491
Deposits
Noninterest-bearing		91,220	89,989
Interest-bearing (including $4,668 and $2,818 of time deposits carried at fair value, respectively)		436,843	422,323
Total deposits		528,063	512,312
Short-term borrowings		17,102	15,279
Long-term debt		52,693	51,480
Other liabilities		29,715	28,649
Total liabilities		627,573	607,720
Shareholders’ equity
Preferred stock		6,808	6,808
Common stock, $.01 par value per share, authorized: 4,000,000,000 shares; issued: 3/31/24 and 12/31/23—2,125,725,742 shares		21	21
Capital surplus		8,642	8,673
Retained earnings		74,473	74,026
Less cost of common stock in treasury: 3/31/24—565,322,411 shares; 12/31/23—567,732,687 shares		(24,023)	(24,126)
Accumulated other comprehensive income (loss)		(10,353)	(10,096)
Total U.S. Bancorp shareholders’ equity		55,568	55,306
Noncontrolling interests		465	465
Total equity		56,033	55,771
Total liabilities and equity		683,606	663,491
Commercial | Commercial
Loans
Total loans		134,726	131,881
Commercial | Commercial real estate
Loans
Total loans		52,677	53,455
Consumer | Residential mortgages
Loans
Total loans		116,079	115,530
Consumer | Credit card
Loans
Total loans		27,844	28,560
Consumer | Other retail
Loans
Total loans		$ 43,262	$ 44,409

[1] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.